J & J; buys $1B Elan Stake, Gains Alzheimer’s R

July 1, 2009

155

Johnson & Johnson has agreed to pay $1 billion for an 18.4% stake in Irish drugmaker Elan Corp, and will acquire most of the rights to Elan’s portfolio of experimental drugs to treat Alzheimer’s disease.

*For more on this story,

read the full Reuters article.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

Would you like to subscribe to Orange County Business Journal?

One-Year for Only $99

Weekly in-depth coverage in print and digital formats
Special Features: OC's Wealthiest, Top Priced Home Sales, Giving Guide, OC500, Charity Event Guide, Best Places to Work, Indispensables, Largest Charitable Gifts
The annual Book of Lists: Orange County's top companies across every industry

California Misses Budget Deadline, Readies “IOUs”

Job Losses Spike in June, Dampen Recovery Hopes

staff-author

J & J; buys $1B Elan Stake, Gains Alzheimer’s R

Want more from the best local business newspaper in the country?

Would you like to subscribe to Orange County Business Journal?

Featured Articles

Fat of the Land Tapas Coming to Centerview in July

Anaheim Distributor Sunrise Produce Acquires Family Tree Produce

Rivian Automotive Upgrades 2026 Delivery Outlook

Related Articles

Fat of the Land Tapas Coming to Centerview in July

Anaheim Distributor Sunrise Produce Acquires Family Tree Produce

Rivian Automotive Upgrades 2026 Delivery Outlook

Midday Stock Roundup: Rivian Up 11%

VEA Newport Beach Collaborates with ‘Top Chef’ Finalist

Advertise With Us

About Us

Subscriber Links

Other Journals